{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:36:24Z","timestamp":1775277384186,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,6,25]],"date-time":"2013-06-25T00:00:00Z","timestamp":1372118400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1038\/bjc.2013.306","type":"journal-article","created":{"date-parts":[[2013,6,25]],"date-time":"2013-06-25T20:06:11Z","timestamp":1372190771000},"page":"164-171","source":"Crossref","is-referenced-by-count":69,"title":["Autophagy inhibition induces enhanced proapoptotic effects of ZD6474 in glioblastoma"],"prefix":"10.1038","volume":"109","author":[{"given":"J","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,25]]},"reference":[{"issue":"4","key":"BFbjc2013306_CR1","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1158\/1078-0432.CCR-10-2634","volume":"17","author":"RK Amaravadi","year":"2011","unstructured":"Amaravadi RK, Lippincott-Schwartz J, Yin XM, Weiss WA, Takebe N, Timmer W, DiPaola RS, Lotze MT, White E (2011) Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res 17 (4): 654\u2013666.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"BFbjc2013306_CR2","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1158\/1535-7163.MCT-07-0568","volume":"7","author":"P Beaudry","year":"2008","unstructured":"Beaudry P, Nilsson M, Rioth M, Prox D, Poon D, Xu L, Zweidler-Mckay P, Ryan A, Folkman J, Ryeom S, Heymach J (2008) Potent antitumor effects of ZD6474 on neuroblastoma via dual targeting of tumor cells and tumor endothelium. Mol Cancer Therap 7 (2): 418\u2013424.","journal-title":"Mol Cancer Therap"},{"issue":"31","key":"BFbjc2013306_CR3","doi-asserted-by":"publisher","first-page":"4762","DOI":"10.1200\/JCO.2010.30.3545","volume":"28","author":"A Broniscer","year":"2010","unstructured":"Broniscer A, Baker JN, Tagen M, Onar-Thomas A, Gilbertson RJ, Davidoff AM, Pai Panandiker AS, Leung W, Chin TK, Stewart CF, Kocak M, Rowland C, Merchant TE, Kaste SC, Gajjar A (2010) Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma. J Clin Oncol 28 (31): 4762\u20134768.","journal-title":"J Clin Oncol"},{"issue":"2","key":"BFbjc2013306_CR4","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1227\/NEU.0b013e3182314f9d","volume":"70","author":"AJ Clark","year":"2012","unstructured":"Clark AJ, Lamborn KR, Butowski NA, Chang SM, Prados MD, Clarke JL, McDermott MW, Parsa AT, Berger MS, Aghi MK (2012) Neurosurgical management and prognosis of patients with glioblastoma that progresses during bevacizumab treatment. Neurosurgery 70 (2): 361\u2013370.","journal-title":"Neurosurgery"},{"issue":"1","key":"BFbjc2013306_CR5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ijrobp.2009.07.1741","volume":"78","author":"J Drappatz","year":"2010","unstructured":"Drappatz J, Norden AD, Wong ET, Doherty LM, Lafrankie DC, Ciampa A, Kesari S, Sceppa C, Gerard M, Phan P, Schiff D, Batchelor TT, Ligon KL, Young G, Muzikansky A, Weiss SE, Wen PY (2010) Phase I study of vandetanib with radiotherapy and temozolomide for newly diagnosed glioblastoma. Int J Radiat Oncol Biol Phys 78 (1): 85\u201390.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFbjc2013306_CR6","doi-asserted-by":"publisher","first-page":"e373","DOI":"10.1038\/cddis.2012.111","volume":"3","author":"C Drullion","year":"2012","unstructured":"Drullion C, Tregoat C, Lagarde V, Tan S, Gioia R, Priault M, Djavaheri-Mergny M, Brisson A, Auberger P, Mahon FX, Pasquet JM (2012) Apoptosis and autophagy have opposite roles on imatinib-induced K562 leukemia cell senescence. Cell Death Dis 3: e373.","journal-title":"Cell Death Dis"},{"issue":"5","key":"BFbjc2013306_CR7","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1002\/hep.25600","volume":"55","author":"M Evert","year":"2012","unstructured":"Evert M, Calvisi DF, Evert K, De Murtas V, Gasparetti G, Mattu S, Destefanis G, Ladu S, Zimmermann A, Delogu S, Thiel S, Thiele A, Ribback S, Dombrowski F (2012) V-AKT murine thymoma viral oncogene homolog\/mammalian target of rapamycin activation induces a module of metabolic changes contributing to growth in insulin-induced hepatocarcinogenesis. Hepatology 55 (5): 1473\u20131484.","journal-title":"Hepatology"},{"issue":"Suppl 4","key":"BFbjc2013306_CR8","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1053\/j.seminoncol.2011.09.008","volume":"38","author":"MR Gilbert","year":"2011","unstructured":"Gilbert MR (2011) Recurrent glioblastoma: a fresh look at current therapies and emerging novel approaches. Semin Oncol 38 (Suppl 4): S21\u2013S33.","journal-title":"Semin Oncol"},{"issue":"6","key":"BFbjc2013306_CR9","doi-asserted-by":"publisher","first-page":"e18691","DOI":"10.1371\/journal.pone.0018691","volume":"6","author":"W Han","year":"2011","unstructured":"Han W, Pan H, Chen Y, Sun J, Wang Y, Li J, Ge W, Feng L, Lin X, Wang X, Jin H (2011) EGFR tyrosine kinase inhibitors activate autophagy as a cytoprotective response in human lung cancer cells. PLoS ONE 6 (6): e18691.","journal-title":"PLoS ONE"},{"issue":"7","key":"BFbjc2013306_CR10","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1158\/0008-5472.CAN-11-3831","volume":"72","author":"YL Hu","year":"2012","unstructured":"Hu YL, DeLay M, Jahangiri A, Molinaro AM, Rose SD, Carbonell WS, Aghi MK (2012a) Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma. Cancer Res 72 (7): 1773\u20131783.","journal-title":"Cancer Res"},{"issue":"17","key":"BFbjc2013306_CR11","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1158\/0008-5472.CAN-12-1076","volume":"72","author":"YL Hu","year":"2012","unstructured":"Hu YL, Jahangiri A, Delay M, Aghi MK (2012) Tumor cell autophagy as an adaptive response mediating resistance to treatments such as antiangiogenic therapy. Cancer Res 72 (17): 4294\u20134299.","journal-title":"Cancer Res"},{"issue":"1","key":"BFbjc2013306_CR12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/jcmm.12001","volume":"17","author":"MV Jain","year":"2013","unstructured":"Jain MV, Paczulla AM, Klonisch T, Dimgba FN, Rao SB, Roberg K, Schweizer F, Lengerke C, Davoodpour P, Palicharla VR, Maddika S, Los M (2013) Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development. J Cell Mol Med 17 (1): 12\u201329.","journal-title":"J Cell Mol Med"},{"issue":"4","key":"BFbjc2013306_CR13","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.cell.2009.03.015","volume":"137","author":"Z Jin","year":"2009","unstructured":"Jin Z, Li Y, Pitti R, Lawrence D, Pham VC, Lill JR, Ashkenazi A (2009) Cullin3-based polyubiquitination and p62-dependent aggregation of caspase-8 mediate extrinsic apoptosis signaling. Cell 137 (4): 721\u2013735.","journal-title":"Cell"},{"issue":"1","key":"BFbjc2013306_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/clpt.2011.272","volume":"91","author":"PB Langmuir","year":"2012","unstructured":"Langmuir PB, Yver A (2012) Vandetanib for the treatment of thyroid cancer. Clin Pharmacol Therap 91 (1): 71\u201380.","journal-title":"Clin Pharmacol Therap"},{"issue":"9","key":"BFbjc2013306_CR15","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/S1470-2045(12)70335-2","volume":"13","author":"S Leboulleux","year":"2012","unstructured":"Leboulleux S, Bastholt L, Krause T, de la Fouchardiere C, Tennvall J, Awada A, Gomez JM, Bonichon F, Leenhardt L, Soufflet C, Licour M, Schlumberger MJ (2012) Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial. Lancet Oncol 13 (9): 897\u2013905.","journal-title":"Lancet Oncol"},{"issue":"10","key":"BFbjc2013306_CR16","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1200\/JCO.2011.36.1709","volume":"30","author":"JS Lee","year":"2012","unstructured":"Lee JS, Hirsh V, Park K, Qin S, Blajman CR, Perng RP, Chen YM, Emerson L, Langmuir P, Manegold C (2012) Vandetanib Versus placebo in patients with advanced non-small-cell lung cancer after prior therapy with an epidermal growth factor receptor tyrosine kinase inhibitor: a randomized, double-blind phase III trial (ZEPHYR). J Clin Oncol 30 (10): 1114\u20131121.","journal-title":"J Clin Oncol"},{"issue":"5","key":"BFbjc2013306_CR17","doi-asserted-by":"publisher","first-page":"600","DOI":"10.4161\/auto.6260","volume":"4","author":"B Levine","year":"2008","unstructured":"Levine B, Sinha S, Kroemer G (2008) Bcl-2 family members: dual regulators of apoptosis and autophagy. Autophagy 4 (5): 600\u2013606.","journal-title":"Autophagy"},{"issue":"14","key":"BFbjc2013306_CR18","doi-asserted-by":"publisher","first-page":"5942","DOI":"10.1158\/0008-5472.CAN-10-0157","volume":"70","author":"X Li","year":"2010","unstructured":"Li X, Fan Z (2010) The epidermal growth factor receptor antibody cetuximab induces autophagy in cancer cells by downregulating HIF-1alpha and Bcl-2 and activating the beclin 1\/hVps34 complex. Cancer Res 70 (14): 5942\u20135952.","journal-title":"Cancer Res"},{"issue":"6","key":"BFbjc2013306_CR19","doi-asserted-by":"publisher","first-page":"e38706","DOI":"10.1371\/journal.pone.0038706","volume":"7","author":"CJ Lin","year":"2012","unstructured":"Lin CJ, Lee CC, Shih YL, Lin CH, Wang SH, Chen TH, Shih CM (2012) Inhibition of mitochondria- and endoplasmic reticulum stress-mediated autophagy augments temozolomide-induced apoptosis in glioma cells. PLoS ONE 7 (6): e38706.","journal-title":"PLoS ONE"},{"issue":"9","key":"BFbjc2013306_CR20","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nrm2239","volume":"8","author":"MC Maiuri","year":"2007","unstructured":"Maiuri MC, Zalckvar E, Kimchi A, Kroemer G (2007) Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 8 (9): 741\u2013752.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"BFbjc2013306_CR21","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.cell.2009.03.048","volume":"137","author":"R Mathew","year":"2009","unstructured":"Mathew R, Karp CM, Beaudoin B, Vuong N, Chen G, Chen HY, Bray K, Reddy A, Bhanot G, Gelinas C, Dipaola RS, Karantza-Wadsworth V, White E (2009) Autophagy suppresses tumorigenesis through elimination of p62. Cell 137 (6): 1062\u20131075.","journal-title":"Cell"},{"issue":"9","key":"BFbjc2013306_CR22","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1158\/1535-7163.1041.3.9","volume":"3","author":"MF McCarty","year":"2004","unstructured":"McCarty MF, Wey J, Stoeltzing O, Liu W, Fan F, Bucana C, Mansfield PF, Ryan AJ, Ellis LM (2004) ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor with additional activity against epidermal growth factor receptor tyrosine kinase, inhibits orthotopic growth and angiogenesis of gastric cancer. Mol Cancer Therap 3 (9): 1041\u20131048.","journal-title":"Mol Cancer Therap"},{"issue":"5","key":"BFbjc2013306_CR23","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/path.2836","volume":"223","author":"AC Navis","year":"2011","unstructured":"Navis AC, Hamans BC, Claes A, Heerschap A, Jeuken JW, Wesseling P, Leenders WP (2011) Effects of targeting the VEGF and PDGF pathways in diffuse orthotopic glioma models. J Pathol 223 (5): 626\u2013634.","journal-title":"J Pathol"},{"key":"#cr-split#-BFbjc2013306_CR24.1","doi-asserted-by":"crossref","unstructured":"1. Rapp M, Goeppert M, Felsberg J, Steiger HJ, Sabel M (2013) The impact of sequential vs. combined radiochemotherapy with temozolomide, resection and MGMT promoter hypermethylation on survival of patients with primary glioblastoma- a single centre retrospective study. Br J Neurosurg","DOI":"10.3109\/02688697.2013.767317"},{"key":"#cr-split#-BFbjc2013306_CR24.2","doi-asserted-by":"crossref","unstructured":"10.3109\/02688697.2013.767317","DOI":"10.3109\/02688697.2013.767317"},{"issue":"22","key":"BFbjc2013306_CR25","doi-asserted-by":"publisher","first-page":"8145","DOI":"10.1158\/1078-0432.CCR-05-0319","volume":"11","author":"JN Rich","year":"2005","unstructured":"Rich JN, Sathornsumetee S, Keir ST, Kieran MW, Laforme A, Kaipainen A, McLendon RE, Graner MW, Rasheed BK, Wang L, Reardon DA, Ryan AJ, Wheeler C, Dimery I, Bigner DD, Friedman HS (2005) ZD6474, a novel tyrosine kinase inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor, inhibits tumor growth of multiple nervous system tumors. Clin Cancer Res 11 (22): 8145\u20138157.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"BFbjc2013306_CR26","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/ijc.26374","volume":"131","author":"S Shimizu","year":"2012","unstructured":"Shimizu S, Takehara T, Hikita H, Kodama T, Tsunematsu H, Miyagi T, Hosui A, Ishida H, Tatsumi T, Kanto T, Hiramatsu N, Fujita N, Yoshimori T, Hayashi N (2012) Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma. Int J Cancer 131 (3): 548\u2013557.","journal-title":"Int J Cancer"},{"issue":"5698","key":"BFbjc2013306_CR27","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1126\/science.1099993","volume":"306","author":"T Shintani","year":"2004","unstructured":"Shintani T, Klionsky DJ (2004) Autophagy in health and disease: a double-edged sword. Science 306 (5698): 990\u2013995.","journal-title":"Science"},{"issue":"5","key":"BFbjc2013306_CR28","doi-asserted-by":"publisher","first-page":"337","DOI":"10.7326\/0003-4819-144-5-200603070-00008","volume":"144","author":"J Sotelo","year":"2006","unstructured":"Sotelo J, Briceno E, Lopez-Gonzalez MA (2006) Adding chloroquine to conventional treatment for glioblastoma multiforme: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 144 (5): 337\u2013343.","journal-title":"Ann Intern Med"},{"issue":"3","key":"BFbjc2013306_CR29","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1093\/carcin\/bgm264","volume":"29","author":"M Tiwari","year":"2008","unstructured":"Tiwari M, Bajpai VK, Sahasrabuddhe AA, Kumar A, Sinha RA, Behari S, Godbole MM (2008) Inhibition of N-(4-hydroxyphenyl)retinamide-induced autophagy at a lower dose enhances cell death in malignant glioma cells. Carcinogenesis 29 (3): 600\u2013609.","journal-title":"Carcinogenesis"},{"issue":"1","key":"BFbjc2013306_CR30","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1093\/carcin\/bgs295","volume":"34","author":"Z Wang","year":"2013","unstructured":"Wang Z, Zhang J, Wang Y, Xing R, Yi C, Zhu H, Chen X, Guo J, Guo W, Li W, Wu L, Lu Y, Liu S (2013) Matrine, a novel autophagy inhibitor, blocks trafficking and the proteolytic activation of lysosomal proteases. Carcinogenesis 34 (1): 128\u2013138.","journal-title":"Carcinogenesis"},{"issue":"6","key":"BFbjc2013306_CR31","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrc3262","volume":"12","author":"E White","year":"2012","unstructured":"White E (2012) Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer 12 (6): 401\u2013410.","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"BFbjc2013306_CR32","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1002\/ijc.22955","volume":"121","author":"X Xiao","year":"2007","unstructured":"Xiao X, Wu J, Zhu X, Zhao P, Zhou J, Liu QQ, Zheng L, Zeng M, Liu R, Huang W (2007) Induction of cell cycle arrest and apoptosis in human nasopharyngeal carcinoma cells by ZD6474, an inhibitor of VEGFR tyrosine kinase with additional activity against EGFR tyrosine kinase. Int J Cancer 121 (9): 2095\u20132104.","journal-title":"Int J Cancer"},{"issue":"12","key":"BFbjc2013306_CR33","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1111\/j.1349-7006.2006.00325.x","volume":"97","author":"Y Yang","year":"2006","unstructured":"Yang Y, Ikezoe T, Nishioka C, Taguchi T, Zhu WG, Koeffler HP, Taguchi H (2006) ZD6474 induces growth arrest and apoptosis of GIST-T1 cells, which is enhanced by concomitant use of sunitinib. Cancer Sci 97 (12): 1404\u20131409.","journal-title":"Cancer Sci"},{"issue":"9","key":"BFbjc2013306_CR34","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1158\/1535-7163.MCT-11-0047","volume":"10","author":"ZJ Yang","year":"2011","unstructured":"Yang ZJ, Chee CE, Huang S, Sinicrope FA (2011) The role of autophagy in cancer: therapeutic implications. Mol Cancer Therap 10 (9): 1533\u20131541.","journal-title":"Mol Cancer Therap"},{"issue":"4","key":"BFbjc2013306_CR35","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1158\/1535-7163.MCT-09-0953","volume":"9","author":"JJ Yiin","year":"2010","unstructured":"Yiin JJ, Hu B, Schornack PA, Sengar RS, Liu KW, Feng H, Lieberman FS, Chiou SH, Sarkaria JN, Wiener EC, Ma HI, Cheng SY (2010) ZD6474, a multitargeted inhibitor for receptor tyrosine kinases, suppresses growth of gliomas expressing an epidermal growth factor receptor mutant, EGFRvIII, in the brain. Mol Cancer Therap 9 (4): 929\u2013941.","journal-title":"Mol Cancer Therap"},{"issue":"2","key":"BFbjc2013306_CR36","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10549-012-2270-7","volume":"136","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Xu S, Lin J, Yao G, Han Z, Liang B, Zou Z, Chen Z, Song Q, Dai Y, Gao T, Liu A, Bai X (2012) mTORC1 is a target of nordihydroguaiaretic acid to prevent breast tumor growth in vitro and in vivo. Breast Cancer Res Treat 136 (2): 379\u2013388.","journal-title":"Breast Cancer Res Treat"},{"issue":"1-2","key":"BFbjc2013306_CR37","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1582-4934.2008.00548.x","volume":"14","author":"P Zhao","year":"2010","unstructured":"Zhao P, Luo R, Wu J, Xie F, Li H, Xiao X, Fu L, Zhu X, Liu R, Zhu Y, Liang Z, Huang W (2010) E10A, an adenovirus carrying human endostatin gene, in combination with docetaxel treatment inhibits prostate cancer growth and metastases. J Cell Mol Med 14 (1-2): 381\u2013391.","journal-title":"J Cell Mol Med"},{"issue":"11","key":"BFbjc2013306_CR38","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1002\/ijc.25975","volume":"129","author":"W Zhuang","year":"2011","unstructured":"Zhuang W, Li B, Long L, Chen L, Huang Q, Liang Z (2011) Induction of autophagy promotes differentiation of glioma-initiating cells and their radiosensitivity. Int J Cancer 129 (11): 2720\u20132731.","journal-title":"Int J Cancer"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2013306.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2013306","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2013306.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T16:12:40Z","timestamp":1688314360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2013306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,25]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["BFbjc2013306"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2013.306","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,25]]}}}